Article
Drugging IGF-1R in cancer: New insights and emerging opportunities
23 Mar 2022
Abstract excerpt
The insulin-like growth factor (IGF) axis plays important roles in cancer development and metastasis. The type 1 IGF receptor (IGF-1R) is a key member in the IGF axis and has long been recognized for its oncogenic role in multiple cancer lineages. Here we review the occurrence of IGF-1R aberrations and activation mechanisms in cancers, which justify the development of anti-IGF-1R therapies. We describe the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
